Bronchospasm

24 registered clinical trials studyying Bronchospasm — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Intraoperative Paravertebral Block and Postoperative Complications NCT07211529	Tongji Hospital	N/A
Completed	Wei Nasal Jet Tube vs Nasal Cannula Oxygen Support in Gastrointestinal Endoscopy Patients NCT05783050	Bezmialem Vakif University	N/A
Completed	Wei Nasal Jet Tube vs Gastro Laryngeal Tube in Endoscopic Retrograde Cholangiopancreatography NCT05360810	Bezmialem Vakif University	N/A
Completed	INHALATION CHAMBER MANAGEMENT IN PEDIATRICS: EFFICACY OF AN EDUCATIONAL INTERVENTION IN PATIENTS DIAGNOSED WIT NCT05555134	Puerta de Hierro University Hospital	N/A
Completed	Bronchospasm During Anesthetic Induction: Study of Clinical Characteristics and Treatments Administered Accord NCT05025709	Central Hospital, Nancy, France	—
Terminated	Avoiding Neuromuscular Blockers to Reduce Complications NCT03962725	Beth Israel Deaconess Medical Center	Phase 4
Completed	Efficacy and Safety of Continuous Infusion of Ketamine in Pediatric Intensive Care Unit (KISS Study) NCT04427605	Azienda Ospedaliera di Padova	—
Completed	Virtual Teach-to-Goal Education vs. Brief Education for Children NCT04373499	University of Chicago	N/A
Completed	Change of Regional Ventilation During Spontaneous Breathing After Lung Surgery NCT02779595	Wuerzburg University Hospital	—
Completed	Driving Pressure And EFL in Adult Cardiac Surgery NCT03064659	Ospedale San Raffaele	—
Completed	Ketamine Efficacy for Acute Severe Bronchospasm in ICU: MACANUDO Trial NCT03000413	Hospital Nossa Senhora da Conceicao	Phase 2 / Phase 3
Completed	Perioperative Change of Regional Ventilation During Spontaneous Breathing NCT02419196	Wuerzburg University Hospital	—
Unknown	Mechanical Ventilation During Cardiac Surgery NCT02090205	Ospedale San Raffaele	N/A
Unknown	Observational Study on Obese Patients During General Anesthesia NCT01488643	Larissa University Hospital	—
Completed	Epinephrine Inhalation Aerosol USP, a HFA-MDI Study for Assessment of Pharmacokinetics NCT01188577	Amphastar Pharmaceuticals, Inc.	Phase 1 / Phase 2
Completed	Escalating and Cumulative-Dose Study of Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of A006 NCT01189396	Amphastar Pharmaceuticals, Inc.	Phase 2
Completed	Dose-Ranging Study of A006 DPI, in Adult Asthma Patients NCT01174732	Amphastar Pharmaceuticals, Inc.	Phase 2
Completed	Prophylactic Efficacy of Relenza Against Influenza A and B NCT01156701	GlaxoSmithKline	—
Completed	A Randomized, Double-Blind, Placebo-Controlled Study of Omalizumab for Idiopathic Anaphylaxis NCT00890162	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 2
Completed	Exercise-Induced Bronchospasm in Cystic Fibrosis NCT00806455	Ohio State University	—
Terminated	Single-Dose Cross-Over Study of the Effects of Albuterol-HFA in Exercise Induced Bronchoconstriction NCT00634829	Amphastar Pharmaceuticals, Inc.	Phase 3
Completed	A First Time In Human Study To Assess The Compound GSK615915 NCT00400660	GlaxoSmithKline	Phase 1
Completed	A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or NCT00118716	GlaxoSmithKline	Phase 4
Completed	A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or NCT00118690	GlaxoSmithKline	Phase 4